Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Source data Rights and permissions Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material
doi: 10.3390/ijms18010120 40 SuLJZhangJHGomezHMuruganRHongXXuDet al
Additional Resources Mercer: GLP-1 Considerations for 2026 Peterson-KFF: Employer Perspectives on GLP-1 Coverage Costs Blue Cross Blue Shield: How GLP-1s Could Increase Employer Premiums Morgan Lewis: GLP-1 Coverage, Obesity, and the ADA Related: ERISA Voluntary Benefits Compliance Checklist for Brokers (BenefitFlow) Sources for statistics cited in this article include SHRM, EBRI, HUB International, KFF, Mercer, Blue Cross Blue Shield Association, and the Business Group on Health
Studies show that weight loss with GLP-1 therapy results in improved left ventricular function and reduced left ventricular mass, enhancing overall cardiac performance
